In a regulatory filing,Treace Medical disclosed that its director John Bakewell bought 130K shares of common stock on May 10th in a total transaction size of $594.6K.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMCI:
- Treace Medical downgraded to Equal Weight from Overweight at Morgan Stanley
- Treace Medical downgraded to Hold from Buy at Truist
- Treace Medical downgraded to Hold from Buy at Stifel
- Treace Medical downgraded to Neutral from Buy at BTIG
- Treace Medical downgraded to Neutral from Overweight at JPMorgan